High E5 expression in HPV+ HNSCC tumors correlated with worse survival, and pharmacological inhibition of E5 in preclinical models elicited a tumor response with increased MHC expression as well as T cell activation. Here, ARHGEF15 is linked to head and neck squamous cell carcinoma.